| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.007 |